Hyperinsulinemia exacerbates the condition by stimulating LH receptors, inhibiting aromatase activity, and lowering sex hormone-binding globulin (SHBG) levels, thereby perpetuating the syndrome’s pathophysiology [43]. This evidence concerns the gene CYP19A1 and hyperinsulinism.